FH and neoplasm: Most have not found any significant difference in tumour size between FH+ and FH− patients (Fukutomi et al, 1993; Israeli et al, 1994; Tsuchiya et al, 1998; Russo et al, 2002), whereas Mohammed observed a trend (Mohammed et al, 1998) and Colditz reported a higher percentage of T1 in women FH+ (60%) vs FH− (54%) (Colditz et al, 1993).